Paediatric Neurology

Our goals are to improve the health and quality of life of children with neurological diseases and offer comprehensive care through collaboration across multidisciplinary teams. Thanks to the implementation of new diagnostic and therapeutic procedures, we can advance our knowledge of molecular causes of, and develop new treatment strategies for, early onset neurological diseases.

The Vall d'Hebron University Hospital has been designated as an ERN in Congenital metabolic diseases (MetabERN) by the European Commission; and the Catalan Health Service has appointed a XUEC for Minority Diseases with Epilepsy in the same hospital.
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 22.12.2022, 11:17
Share it

Notícies relacionades

Subscribe to our newsletters and be a part of Campus Life

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.